📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Serum immunoglobulin levels and the risk of bladder cancer in the AMORIS Cohort. (2019)

First Author: Peppas I

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.canep.2019.101584

PubMed Identifier: 31451416

Publication URI: http://europepmc.org/abstract/MED/31451416

Type: Journal Article/Review

Volume: 62

Parent Publication: Cancer epidemiology

ISSN: 1877-7821